Gary M. Phillips - 10 Jun 2025 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Gary Phillips
Issuer symbol
ALDX
Transactions as of
10 Jun 2025
Net transactions value
$0
Form type
4
Filing time
12 Jun 2025, 16:21:47 UTC
Previous filing
06 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Phillips Gary M. Director C/O ALDEYRA THERAPEUTICS, INC., 131 HARTWELL AVENUE, LEXINGTON /s/ Gary Phillips 12 Jun 2025 0001197795

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +62,728 $0.000000 62,728 10 Jun 2025 Common Stock 62,728 $2.68 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +4,825 $0.000000 4,825 10 Jun 2025 Common Stock 4,825 $2.68 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +3,619 $0.000000 3,619 10 Jun 2025 Common Stock 3,619 $2.68 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.